|
|
|
eMedicine Journal
>
Emergency Medicine
>
Ear, Nose, And Throat
Retropharyngeal Abscess Synonyms, Key Words, and Related Terms: RPA, retropharyngeal space infection, mediastinitis, Staphylococcus aureus, Bacteroides, Veillonella, Haemophilus parainfluenzae, internal jugular vein thrombosis, carotid artery erosion, pericarditis, epidural abscess, deep cervical space infections, sepsis, airway compromise |
||||||||||
|
Author Information | Introduction | Clinical | Differentials | Workup | Treatment | Medication | Follow-up | Miscellaneous | Test Questions | Pictures | Bibliography
|
| AUTHOR INFORMATION | Section 1 of 12 |
Authored by Joseph Kahn, MD, Director of Medical Student Education, Clinical Associate Professor, Department of Emergency Medicine, Boston Medical Center
Joseph Kahn, MD, is a member of the following medical societies: American College of Emergency Physicians, Massachusetts Medical Society, Physicians for Social Responsibility, and Society for Academic Emergency Medicine
Edited by Michael Glick, DMD, Professor and Acting Chair, Department of Diagnostic Sciences, New Jersey Dental School, University of Medicine and Dentistry of New Jersey; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Mark W Fourre, MD, Program Director, Department of Emergency Medicine, Maine Medical Center, Associate Clinical Professor, Department of Surgery, University of Vermont School of Medicine; John Halamka, MD, Chief Information Officer, CareGroup Healthcare System, Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School; and Robert E O'Connor, MD, MPH, Director of Education and Research, Department of Emergency Medicine, Christiana Care Health System; Professor of Emergency Medicine, Thomas Jefferson University
| Author's Email: | Joseph Kahn, MD | |
|---|---|---|
| Editor's Email: | Michael Glick, DMD |
eMedicine Journal, October 19 2005, VOLUME 6,
Number 10
| INTRODUCTION | Section 2 of 12 |
Background: Retropharyngeal abscess (RPA) occurs much less commonly today than in the past because of the widespread use of antibiotics for suppurative upper respiratory infections. RPA, once almost exclusively a disease of children, is observed with increasing frequency in adults. RPA poses a diagnostic challenge for the emergency physician because of its rare occurrence and variable presentation.
Early recognition and aggressive management of RPA are essential because RPA still carries significant morbidity and mortality.
Pathophysiology: The retropharyngeal space is posterior to the pharynx, bound by the buccopharyngeal fascia anteriorly, the prevertebral fascia posteriorly, and the carotid sheaths laterally. It extends superiorly to the base of the skull and inferiorly to the mediastinum.
Abscesses in this space can be caused by the following organisms:
The high mortality rate of RPA is owing to its association with airway obstruction, mediastinitis, aspiration pneumonia, epidural abscess, jugular venous thrombosis, and erosion into the carotid artery.
Mortality/Morbidity: Once mediastinitis occurs, mortality approaches 50%, even with antibiotic therapy. RPA can also cause internal jugular vein thrombosis, carotid artery erosion, pericarditis, and epidural abscess. In addition to invasion of contiguous structures, RPA can cause sepsis and airway compromise.
Overall mortality was 1% in a recent review of deep cervical space infections in Taiwan.
Race:
Sex: RPA is more common in males than in females, with generally reported male preponderance of 53-55%.
Age: Initially, RPA was thought to be a disease limited to children, but now it is being encountered with increasing frequency in adults.
| CLINICAL | Section 3 of 12 |
History: History is variable, depending on the age group. Symptoms are different for adults, children, and infants.
Physical: Patients with RPA may present with signs of airway obstruction, but often they do not. Individuals who do not exhibit signs of airway obstruction initially may progress to airway obstruction. The most common presenting signs may be different for adult and pediatric patients.
Causes: RPA develops secondary to lymphatic drainage or contiguous spread of upper respiratory or oral infections. Pharyngeal trauma from endotracheal intubation, endoscopy, foreign body ingestion, and removal may cause a subsequent RPA. Patients who are immunocompromised or chronically ill, such as persons with diabetes, cancer, alcoholism, or AIDS, are at increased risk for RPA.
The most common organisms causing retropharyngeal abscesses include aerobes and anaerobes; gram-negative organisms also may be observed. Often, mixed flora are cultured.
| DIFFERENTIALS | Section 4 of 12 |
Angioedema
Dental, Infections
Epidural and Subdural Infections
Epiglottitis, Adult
Esophagitis
Foreign Bodies, Gastrointestinal
Foreign Bodies, Trachea
Mediastinitis
Meningitis
Mononucleosis
Otitis Media
Pediatrics, Croup or Laryngotracheobronchitis
Pediatrics, Epiglottitis
Pediatrics, Fever
Pediatrics, Foreign Body Ingestion
Pediatrics, Meningitis and Encephalitis
Pediatrics, Otitis Media
Pediatrics, Pharyngitis
Pediatrics, Pneumonia
Peritonsillar Abscess
Pharyngitis
Pneumonia, Bacterial
Sinusitis
Torticollis
Toxicity, Caustic Ingestions
Other Problems to be Considered:
Airway obstruction
| WORKUP | Section 5 of 12 |
Lab Studies:
Imaging Studies:
Procedures:
| TREATMENT | Section 6 of 12 |
Prehospital Care:
Emergency Department Care: ED management of RPA includes attention to the airway, fluid resuscitation if necessary, antibiotic treatment, and preparation for an emergency operation. Frequent vital sign checks and continuous oxygen saturation monitoring are essential.
Consultations: An emergent consultation with an ear, nose, and throat (ENT) specialist is necessary.
| MEDICATION | Section 7 of 12 |
The goals of pharmacotherapy are to eradicate the infection, to reduce morbidity, and to prevent complications. IV broad-spectrum antibiotic coverage is indicated in the treatment of RPA.
Drug Category: Antibiotics -- Gram-positive organisms (including beta-lactamase producing), gram-negative organisms, and anaerobes must be covered. The list of antibiotic regimens in the table below is from The Sanford Guide to Antimicrobial Therapy 2005.
Some recommend the following regimens, which were not mentioned in the Sanford guide: penicillin and oxacillin, second- or third-generation cephalosporin and clindamycin, penicillinase-resistant penicillin combined with either clindamycin or metronidazole, or third-generation cephalosporin in combination with clindamycin, nafcillin, or both (triple therapy).
| Drug Name | Clindamycin (Cleocin) -- Inhibits bacterial protein synthesis by inhibiting peptide chain initiation at the bacterial ribosome where it preferentially binds to the 50S ribosomal subunit, causing bacterial growth inhibition. |
|---|---|
| Adult Dose | 600-900 mg IV q8h |
| Pediatric Dose | 25-40 mg/kg/d IV divided q6-8h |
| Contraindications | Documented hypersensitivity; regional enteritis, ulcerative colitis, hepatic impairment, antibiotic-associated colitis |
| Interactions | Increases duration of neuromuscular blockade induced by tubocurarine and pancuronium; erythromycin may antagonize effects; antidiarrheals may delay absorption |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Adjust dose in severe hepatic dysfunction; no adjustment necessary in renal insufficiency; associated with severe and possibly fatal colitis |
| Drug Name | Penicillin G (Pfizerpen) and metronidazole (Flagyl) -- Second DOC, Penicillin G interferes with the synthesis of cell wall mucopeptide during active multiplication resulting in bactericidal activity against susceptible microorganisms. Metronidazole is active against various anaerobic bacteria and protozoa. Cells of microorganisms that contain nitroreductase absorb metronidazole. Unstable intermediate compounds are then formed that bind DNA and inhibit synthesis, causing cell death. |
|---|---|
| Adult Dose | Penicillin G 24 million U/d IV by continuous infusion or divided q4-6h, plus metronidazole 1 g IV loading dose, followed by metronidazole 500 mg IV q6h |
| Pediatric Dose | Penicillin G 25,000 U/kg IV q6h, plus metronidazole 30 mg/kg/d IV divided q8h |
| Contraindications | Documented hypersensitivity |
| Interactions | Penicillin G: Probenecid can increase effects; coadministration of tetracyclines can decrease effects Metronidazole: May increase toxicity of anticoagulants, lithium, and phenytoin; cimetidine may increase toxicity; disulfiram reaction may occur with orally ingested ethanol |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Penicillin G: Caution in impaired renal function Metronidazole: Adjust dose in hepatic disease; monitor for seizures and development of peripheral neuropathy |
| Drug Name | Cefoxitin (Mefoxin) -- Considered an alternative therapy. A second-generation cephalosporin indicated for the management of infections caused by susceptible gram-positive cocci and gram-negative rods. Many infections caused by gram-negative bacteria resistant to some cephalosporins and penicillins respond to cefoxitin. |
|---|---|
| Adult Dose | 2 g IV q8h |
| Pediatric Dose | 80-160 mg/kg/d IV divided q6h |
| Contraindications | Documented hypersensitivity; regional enteritis; ulcerative colitis; hepatic impairment; antibiotic-associated colitis |
| Interactions | Probenecid may increase effects; coadministration with aminoglycosides or furosemide may increase nephrotoxicity (closely monitor renal function) |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Bacterial or fungal overgrowth of nonsusceptible organisms may occur with prolonged use or repeated treatment; caution in patients with previously diagnosed colitis |
| Drug Name | Ticarcillin and clavulanate (Timentin) -- Alternative treatment that inhibits biosynthesis of cell wall mucopeptide and is effective during stage of active growth. Antipseudomonal penicillin plus beta-lactamase inhibitor that provides coverage against most gram-positive organisms, most gram-negative organisms, and most anaerobes. |
|---|---|
| Adult Dose | 3.1 g IV q6h |
| Pediatric Dose | 100 mg/kg IV q8h |
| Contraindications | Documented hypersensitivity; severe pneumonia, bacteremia, pericarditis, emphysema, meningitis, and purulent or septic arthritis should not be treated with oral penicillin during acute stage |
| Interactions | Tetracyclines may decrease effects of ticarcillin; high concentrations of ticarcillin may physically inactivate aminoglycosides if administered in same IV line; effects when administered concurrently with aminoglycosides are synergistic; probenecid may increase penicillin levels |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Perform CBCs before initiation of therapy and at least weekly during therapy; monitor for liver function abnormalities by measuring AST and ALT during therapy; exercise caution in patients with hepatic insufficiencies; perform urinalysis, and BUN and creatinine determinations during therapy and adjust dose if values become elevated; monitor blood levels to avoid possible neurotoxic reactions |
| Drug Name | Piperacillin and tazobactam (Zosyn) -- Antipseudomonal penicillin plus beta-lactamase inhibitor. Inhibits the biosynthesis of cell wall mucopeptide and is effective during the stage of active multiplication. |
|---|---|
| Adult Dose | 3.375 g IV q6h or 4.5 g q8h |
| Pediatric Dose | 75 mg/kg IV q6h |
| Contraindications | Documented hypersensitivity; severe pneumonia, bacteremia, pericarditis, emphysema, meningitis, and purulent or septic arthritis should not be treated with an oral penicillin during the acute stage |
| Interactions | Tetracyclines may decrease effects of ticarcillin; high concentrations of ticarcillin may physically inactivate aminoglycosides if administered in same IV line; effects when administered concurrently with aminoglycosides are synergistic; probenecid may increase penicillin levels |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Perform CBCs before initiation of therapy and at least weekly during therapy; monitor for liver function abnormalities by measuring AST and ALT during therapy; exercise caution in patients with hepatic insufficiencies; perform urinalysis and BUN and creatinine determinations during therapy and adjust dose if values become elevated; monitor blood levels to avoid possible neurotoxic reactions |
| Drug Name | Ampicillin and sulbactam (Unasyn) -- Drug combination that utilizes a beta-lactamase inhibitor with ampicillin, which covers skin, enteric flora, and anaerobes but is not ideal for nosocomial pathogens. |
|---|---|
| Adult Dose | 3 g IV/IM q6h |
| Pediatric Dose | 25 mg/kg IV/IM q6h |
| Contraindications | Documented hypersensitivity |
| Interactions | Probenecid and disulfiram elevate ampicillin levels; allopurinol decreases ampicillin effects and has additive effects on ampicillin rash; may decrease effects of oral contraceptives |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Adjust dose in renal failure; evaluate rash and differentiate from hypersensitivity reaction |
| FOLLOW-UP | Section 8 of 12 |
Further Inpatient Care:
Transfer:
Deterrence/Prevention:
Complications:
Prognosis:
Patient Education:
| MISCELLANEOUS | Section 9 of 12 |
Medical/Legal Pitfalls:
| TEST QUESTIONS | Section 10 of 12 |
CME Question 1: Which of the following may be a complication of a retropharyngeal abscess?
A: Airway obstruction
B: Mediastinitis
C: Aspiration pneumonia
D: Sepsis
E: All of the above
The correct answer is E: Many complications of retropharyngeal abscesses may occur, including airway obstruction, mediastinitis, aspiration pneumonia, sepsis, epidural abscess, atlantooccipital dislocation, pleural involvement, acute respiratory distress syndrome (ARDS), erosion of the second and third cervical vertebrae, cranial nerve deficits, septic thrombosis of the jugular vein, and hemorrhage secondary to erosion into the carotid artery.
CME Question 2: A 5-year-old boy presents with a worsening sore throat for 5 days with a temperature of 102° F. He is not in respiratory distress and can swallow with pain. An inflamed bulging pharynx is observed on examination. What is the most appropriate treatment?
A: Attempt incision and drainage of the retropharyngeal space in the ED.
B: Discharge the patient on penicillin and arrange follow-up with an ear, nose, and throat (ENT) specialist the next day.
C: Order a lateral soft tissue neck x-ray and proceed to treat other patients.
D: Notify an ENT specialist and send the patient for a lateral soft tissue neck x-ray accompanied by emergency airway equipment and personnel who know how to use it.
E: Palpate the retropharyngeal bulge to see if it is fluctuant.
The correct answer is D: A child with retropharyngeal abscess (RPA) should not have the pharynx palpated or incised in the ED because of the risk of rupturing the abscess and causing aspiration pneumonia. RPAs cannot be treated on an outpatient basis with antibiotics because of risk of airway obstruction. Children should not be sent for an x-ray unaccompanied because of risk of airway obstruction. The safest course of action is to notify the ENT specialist early and obtain the soft tissue lateral neck x-ray while the child is being observed closely by someone trained in advanced airway management with airway equipment available.
Pearl Question 1 (T/F): Staphylococcus aureus and group A beta-hemolytic streptococci are 2 causes of retropharyngeal abscess (RPA) in children.
The correct answer is True: Staphylococcus aureus, group A beta-hemolytic streptococci, Haemophilus species, Bacteroides species, Peptostreptococcus species, Fusobacterium species, Prevotella species, Pseudomonas aeruginosa, and Staphylococcus coagulase negative are all causes of RPA in children.
Pearl Question 2 (T/F): Beta-hemolytic streptococci, Streptococcus viridans, Staphylococcus aureus, and Klebsiella pneumoniae all may cause retropharyngeal abscess (RPA) in adults.
The correct answer is True: Beta-hemolytic streptococci, anaerobic streptococci, Streptococcus viridans, Staphylococcus aureus, Klebsiella pneumoniae, Staphylococcus epidermidis, Escherichia coli, Mycobacterium tuberculosis, Bacteroides species, Prevotella species, and Pseudomonas aeruginosa are all causes of RPA in adults.
Pearl Question 3 (T/F): A CT scan of the neck with IV contrast can confirm the presence and extent of retropharyngeal abscess (RPA) suspected clinically or on soft tissue lateral neck x-ray.
The correct answer is True: A CT scan of the neck with IV contrast can confirm presence and extent of RPA; an MRI probably would work also, but has not been used widely for this.
Pearl Question 4 (T/F): Penicillin G plus metronidazole, cefoxitin, or clindamycin may be used to treat retropharyngeal abscess (RPA) empirically while cultures are pending.
The correct answer is True: Penicillin G plus metronidazole, cefoxitin, clindamycin, ticarcillin and clavulanate, piperacillin and tazobactam, and ampicillin and sulbactam are all antibiotics that may be used to treat RPA.
| PICTURES | Section 11 of 12 |
| Caption: Picture 1. A 5-year-old boy presented to the ED with 2 days of neck pain and fever but with no sore throat. The child had vomited once, and the mother reported that he was irritable. The child's temperature was 101.7° F, pulse was 118 beats per minute, respirations were 24 per minute, and blood pressure was 122/65 mm Hg. A decreased range of motion of the neck and a right anterior cervical node were observed; the child refused to swallow. Lateral neck x-ray findings show increased retropharyngeal space (white arrow). The CT scan did not demonstrate an abscess. The child was seen by an ear, nose, and throat specialist; he was admitted and started on intravenous clindamycin. He improved for 2-3 days and then worsened. Repeat neck CT scan findings demonstrated a retropharyngeal abscess. Incision and drainage was performed in the operating room. Cultures of the pus grew group A beta-hemolytic streptococci and alpha-streptococci, both sensitive to clindamycin. He improved and was discharged on the tenth hospital day on oral clindamycin. | |
![]() | View Full Size Image |
eMedicine Zoom View (Interactive!) | |
| Picture Type: X-RAY | |
| Caption: Picture 2. An 8-month-old infant boy presented with fever and a stiff neck. According to the mother, the baby was not moving his neck as much as usual. The mother also reported decreased oral intake. His temperature was 100° F, pulse was 104 beats per minute, respirations were 48 per minute, oxygen saturation was 98% (room air [RA]). The left tympanic membrane (TM) was inflamed and nonmobile. Left submandibular and left postauricular nodes were noted. The lateral neck x-ray film shows increased retropharyngeal space. The CT scan demonstrated a small retropharyngeal abscess. The WBC count was 26,000 (24 polymorphonuclear leukocytes [P], 5 bands [B], 63 lymphocytes [L], 8 monocytes [M]). The baby was examined by an ear, nose, and throat specialist; he was admitted and started on IV clindamycin. He improved over the next few days and was discharged on the fifth hospital day on oral clindamycin with plan for repeat CT scans of the neck on an outpatientbasis. | |
![]() | View Full Size Image |
eMedicine Zoom View (Interactive!) | |
| Picture Type: X-RAY | |
| BIBLIOGRAPHY | Section 12 of 12 |
| NOTE: |
|---|
| Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER |
| eMedicine Journals > Emergency Medicine > Ear, Nose, And Throat > Retropharyngeal Abscess |
| Please email us with any comments you have on our new chapter format. |
|
Author Information | Introduction | Clinical | Differentials | Workup | Treatment | Medication | Follow-up | Miscellaneous | Test Questions | Pictures | Bibliography
|
|